Variables | Case group (n = 354) | Control group (n = 1498) | test SMD/Z/2 | P |
---|---|---|---|---|
Age (years)/(xs) | 61.56 ± 9.78 | 58.91 ± 13.87 | 0.221 | 0.085 |
Body mass index (Kg/m2)/ (M(P25,P75)) | 25.74(24.10,27.44) | 24.22(22.49,26.22) | −13.686 |  < 0.001 |
Red blood cell (× 1012/L)/ (M(P25,P75)) | 4.60(4.18,4.92) | 4.79(4.50,5.03) | −8.022 |  < 0.001 |
Hemoglobin (g/L)/(M(P25,P75)) | 139.00(123.00,150.00) | 148.00(140.00,155.00) | −15.824 |  < 0.001 |
Mean corpuscular volume (fl)/ (M(P25,P75)) | 91.90(88.65,94.70) | 93.20(90.80,95.00) | −8.984 |  < 0.001 |
Mean corpuscular hemoglobin (pg)/ (M(P25,P75)) | 30.20(29.30,31.40) | 30.50(29.60,31.40) | −2.705 | 0.007 |
Mean corpuscular hemoglobin concentration (g/L)/(M(P25,P75)) | 333.00(327.00,340.00) | 333.00(325.00,339.00) | −2.925 | 0.003 |
Red cell distribution width (%)/ (M(P25,P75)) | 12.70(12.30,13.30) | 12.60(12.20,13.20) | −1.866 | 0.062 |
Platelet count (× 109/L)/ (M(P25,P75)) | 219.60(191.00,254.00) | 215.00(183.00,253.72) | −1.491 | 0.136 |
Mean platelet volume (MPV) (f1)/ (M(P25,P75)) | 9.50(8.90,10.40) | 9.10(8.50,10.00) | −8.484 |  < 0.001 |
Plateletocrit (%)/(M(P25,P75)) | 0.21(0.18,0.24) | 0.20(0.17,0.23) | −5.807 |  < 0.001 |
Platelet distribution width (%)/ (M(P25,P75)) | 15.70(11.10,16.40) | 16.00(15.40,16.50) | −8.484 |  < 0.001 |
Aspartate aminotransferase (AST) (U/L)/(M(P25,P75)) | 23.99(18.50,28.60) | 20.30(17.30,23.80) | −12.495 |  < 0.001 |
Alanine aminotransferase (ALT) (U/L)/(M(P25,P75)) | 25.12(18.19,37.13) | 20.70(15.10,27.84) | −12.017 |  < 0.001 |
Lactate dehydrogenase (U/L)/(M(P25,P75)) | 169.00(151.14,211.03) | 169.315(155.30,182.31) | −5.592 |  < 0.001 |
γ-glutamyl transpeptidase (U/L)/(M(P25,P75)) | 30.00(21.00,44.49) | 24.30(18.02,35.60) | −9.156 |  < 0.001 |
Alkaline phosphatase (U/L)/(M(P25,P75)) | 88.36(64.30,184.60) | 73.40(62.93,88.00) | −12.299 |  < 0.001 |
Fasting glucose (FG) (mmol)/(M(P25,P75)) | 5.41(4.92,6.59) | 5.11(4.67,5.61) | −11.913 |  < 0.001 |
Fasting triglycerides (TG) (mmol)/(M(P25,P75)) | 1.36(1.07,1.75) | 1.20(0.90,1.63) | −7.982 |  < 0.001 |
Total cholesterol (mmol)/(M(P25,P75)) | 4.04(3.45,4.75) | 4.61(4.02,5.29) | −15.205 |  < 0.001 |
High-density lipoprotein cholesterol (mmol)/(M(P25,P75)) | 0.99(0.84,1.26) | 1.21(1.03,1.38) | −15.979 |  < 0.001 |
Low-density lipoprotein cholesterol (mmol)/(M(P25,P75)) | 2.76(2.16,3.28) | 2.82(2.40,3.35) | −5.289 |  < 0.001 |
Waist circumference (cm)/(M(P25,P75)) | 94.00(90.00,104.00) | 87.00(82.00,92.00) | −23.295 |  < 0.001 |
Blood potassium (mmol/L)/(M(P25,P75)) | 3.98(3.70,4.26) | 4.06(3.80,4.33) | −6.112 |  < 0.001 |
Blood sodium (mmol/L)/(M(P25,P75)) | 140.90(139.10,142.79) | 141.20(140.00,143.00) | −4.226 |  < 0.001 |
Blood chlorine (mmol/L)/(M(P25,P75)) | 104.60(103.00,106.80) | 104.30(102.50,106.30) | −1.948 | 0.051 |
Blood calcium (mmol/L)/(M(P25,P75)) | 2.23(2.15,2.30) | 2.32(2.21,2.40) | −15.705 |  < 0.001 |
Serum magnesium (mmol/L)/(M(P25,P75)) | 0.85(0.82,0.91) | 0.85(0.80,0.91) | −1.833 | 0.067 |
Serum phosphorus (mmol/L)/(M(P25,P75)) | 1.15(1.01,1.27) | 0.97(0.86,1.08) | −22.935 |  < 0.001 |
Serum creatinine (μmol/L)/(M(P25,P75)) | 78.98(64.68,89.28) | 79.50(70.00,88.60) | −3.505 |  < 0.001 |
ZJU index/(M(P25,P75)) | 36.62(34.26,39.62) | 34.11(31.57,36.68) | −17.987 |  < 0.001 |
ZJU index/(%) |  |  | 279.252 |  < 0.001 |
Q1(≤ 31.57) | 10.6% | 26.2% |  |  |
Q2(31.58 −34.04) | 13.5% | 22.3% |  |  |
Q3(34.05—35.87) | 15.9% | 20.2% |  |  |
Q4(35.88—38.34) | 28.2% | 17.6% |  |  |
Q5(≥ 38.35) | 31.7% | 13.7% |  |  |
TyG index/(M(P25,P75)) | 8.73(8.38,9.02) | 8.51(8.15,8.85) | −12.306 |  < 0.001 |
TyG index/(%) |  |  | 168.382 |  < 0.001 |
Q1(≤ 8.14) | 11.6% | 24.7% |  |  |
Q2(8.15—8.45) | 18.0% | 21.3% |  |  |
Q3(8.46—8.73) | 19.6% | 19.8% |  |  |
Q4(8.74—8.98) | 19.9% | 20.0% |  |  |
Q5(≥ 8.99) | 30.9% | 14.2% |  |  |
TG/HDL-c/(M(P25,P75)) | 3.31(2.06,4.35) | 2.37(1.64,3.34) | −14.596 |  < 0.001 |
TG/HDL-c/(%) |  |  | 233.207 |  < 0.001 |
Q1(≤ 1.64) | 10.4% | 25.0% |  |  |
Q2(1.65—2.24) | 18.7% | 20.7% |  |  |
Q3(2.25—2.96) | 16.6% | 21.9% |  |  |
Q4(2.97—3.96) | 21.5% | 19.2% |  |  |
Q5(≥ 3.97) | 32.8% | 13.2% |  |  |
METS-IR/(M(P25,P75)) | 42.61(37.79,46.90) | 38.27(34.00,42.08) | −17.221 |  < 0.001 |
METS-IR/(%) |  |  | 275.630 |  < 0.001 |
Q1(≤ 34.21) | 9.3% | 25.5% |  |  |
Q2(34.22—37.89) | 16.4% | 22.2% |  |  |
Q3(37.90—41.13) | 17.5% | 21.4% |  |  |
Q4(41.14—44.96) | 23.6% | 18.1% |  |  |
Q5(≥ 44.97) | 33.2% | 12.9% |  |  |